---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-061610"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2021-11-23T23:59:59+00:00"
generated_at: "2026-06-28T05:40:01.538454+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# China Pharma raises $5M via convertible note to Streeterville Capital with 5% interest and 15-month maturity

## Summary
- Issued unsecured convertible promissory note for $5.25M principal ($5M net proceeds after $250K OID) to Streeterville Capital.
- Note carries 5% annual interest; upon default, interest rises to 22% and balance accelerates with 15% or 5% penalty.
- Company reserved 30M common shares for conversion; conversion price at 85% of lowest 10-day VWAP during prior 10 trading days.
- Proceeds used for general working capital; Streeterville's consent required for fundamental transactions.
- Company must file prospectus supplement within 30 days to register up to $5M of common stock for investor.

## SEC filing metadata
- accession: 0001213900-21-061610
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2021-11-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390021061610/0001213900-21-061610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390021061610/ea151262-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-061610
- JSON: https://secwatch.observer/filing/0001213900-21-061610.json
- Plain text: https://secwatch.observer/filing/0001213900-21-061610.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.